Completed
A Microdose Study in Healthy Subjects to Describe Intravenous Pharmacokinetics of GSK3191607
NCT02737007
- Conditions
- Infections, Malaria, Malaria, Falciparum, +4 more
- Locations
-
- GSK Investigational Site London, United Kingdom